Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1857 News Items found Brain Trust: 8 Questions with Ingo Mellinghoff Thursday, March 11, 2021 Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology. In the Clinic High-Dose Radiation Offers Hope for People with Inoperable Pancreatic Cancer Thursday, March 11, 2021 A high-dose radiation treatment is effective for pancreatic cancer patients who cannot have surgery. MSK Partners with Nassau County to Equitably Distribute COVID-19 Vaccines Wednesday, March 10, 2021 In partnership with the Nassau County Department of Health, MSK Nassau will help equitably distribute COVID-19 vaccinations. The National Cancer Act @ 50: The First "Cancer Centers" Monday, March 8, 2021 This year, MSK joins the National Cancer Institute and the larger cancer community in commemorating the 50th anniversary of the signing of the National Cancer Act of 1971. Women Leaders at MSK: Mini Kamboj Monday, March 8, 2021 Mini Kamboj says encouragement from her family during her early years help mold her into the strong, self-possessed leader needed to guide MSK through the COVID-19 pandemic. ‘Aren’t I Too Young?’ How MSK Helps People under 50 with Colorectal and GI Cancers Monday, March 8, 2021 Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50. Researchers Report Excellent Outcomes for New Leukemia and Lymphoma Drug Friday, March 5, 2021 The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study. Feature In Memoriam: Developmental Biologist Kathryn V. Anderson Monday, March 1, 2021 Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute. MSK a Founding Member of Break Through Cancer Thursday, February 25, 2021 MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers. In the Lab Clearing the Fog around Tumor Mutational Burden Monday, February 22, 2021 MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs. Pagination First page « First Previous page ‹ Previous … Page 81 Page 82 Page 83 Page 84 Current page 85 Page 86 Page 87 Page 88 Page 89 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment